1-1-3 Otemachi
Chiyoda-ku
Tokyo 100-0004
Japan
81 3 5219 5100
https://www.alfresa.com
Sector(es): Healthcare
Industria: Medical Distribution
Empleados a tiempo completo:
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Ryuji Arakawa | President & Representative Director | N/D | N/D | 1963 |
Toshiki Tanaka | VP, Executive Officer of Gen Affairs, HR Planning, Digital Transformation (DX) and Compliance & Dir | N/D | N/D | 1963 |
Mr. Seiichi Kishida | Executive VP, Assistant to the President & Representative Director | N/D | N/D | 1960 |
Mr. Yusuke Fukujin | Executive VP & Representative Director | N/D | N/D | 1976 |
Shigeki Ohashi | VP, Exe. Officer of Grp Bus, Affiliate Control, Bus Dev & International Business and Director | N/D | N/D | 1965 |
Kazuaki Hano | Executive Officer | N/D | N/D | N/D |
Soichi Nemoto | Executive Officer | N/D | N/D | N/D |
Toshikazu Urakabe | Executive Officer | N/D | N/D | N/D |
Takashi Sasaki | Executive Officer | N/D | N/D | N/D |
Miki Oguchi | Executive Officer | N/D | N/D | N/D |
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.
La calificación ISS Governance QuickScore de Alfresa Holdings Corporation a partir del 1 de mayo de 2024 es 10. Las puntuaciones principales son Auditoría: 4; Junta: 9; Derechos del accionista: 8; Compensación: 6.